ÂÜÀòÂÒÂ×

Nicholas Franano, MD, is a physician, scientist, inventor, and entrepreneur. He is President and CEO of Artio Medical, and a co-founder. Dr. Franano is an experienced entrepreneur, founding several companies including Artio Medical, Flow Forward Medical, Novita Therapeutics, and Proteon Therapeutics (NYSE: PRTO). Dr. Franano has held positions of President, CEO, and CSO at these companies, which have raised collectively over $120 million in capital and grants.

Before Proteon, Dr. Franano maintained an active clinical practice in interventional radiology, performing a wide range of vascular and non-vascular procedures. He received both his Doctor of Medicine and Master of Science in biomedical research from Washington University in St. Louis. He completed a residency in Diagnostic Radiology and a fellowship in Interventional Radiology at Johns Hopkins Hospital. He has received numerous research awards, grants and fellowships, and has published many abstracts and articles in peer-reviewed journals.